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Abstract
Background: Although various placebo acupuncture devices have been developed and used in acupuncture
research, there is controversy concerning whether these devices really serve as appropriate placebos for control
groups.
Methods/Design: The proposed study is a single-center prospective random sequence participant- and assessor-
blinded trial with two parallel arms. A total of 76 participants will be randomly assigned to Group 1 or Group 2 in a
1:1 ratio. Group 1 will consist of Sham Streitberger’s needle, Real Streitberger’s needle, and Phantom acupuncture
session. Group 2 will consist of Park Sham device with real needle, Park Sham device with sham needle, and no
treatment session. Participants will have a total of three acupuncture sessions in a day. The primary endpoint is
blinding test questionnaire 1. Secondary endpoints are the Bang’s blinding index, the Massachusetts General
Hospital Acupuncture Sensation Scale index, and physiological data including heart rate, heart rate variability, and
skin conductance response.
Discussion: This trial will evaluate the relevance of using placebo acupuncture devices as controls using a
validation test procedure.
Trial registration: Clinical Research Information Service: KCT0001347.
Keywords: Placebo acupuncture, Blinding, Validation, Park sham device, Streitberger’s needle, Phantom
acupuncture
Background
Acupuncture is a treatment modality that has been used
in Eastern Asia for more than 2000 years. An increased
interest in the clinical effects of acupuncture has also
been expressed in the West in recent years. In a 1997
report on the effects of acupuncture, the National
Institutes of Health (NIH) stressed the need for evidence
of efficacy [1]. Subsequently, the number of randomized
controlled clinical trials (RCTs) using acupuncture to
treat various conditions has rapidly increased; however,
many acupuncture clinical trials have methodological
limitations. Establishing appropriate placebo control
groups is one of several issues. Ideally, placebo acupun-
cture should satisfy two conditions: (1) it should be
indistinguishable from real acupuncture to blinded
participants, and (2) it should be physiologically inert.
Various placebo acupuncture devices that satisfy these
conditions have been developed and used in acupuncture
clinical trials.
Currently, there are two types of acupuncture con-
trols: (1) sham acupuncture, in which real acupunc-
ture needles are inserted into the skin either fully at
non-acupuncture points or superficially at acupunc-
ture points, non-acupuncture points, or non-relevant
acupuncture points with certain conditions, and (2)
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placebo acupuncture, which uses non-penetrating acu-
puncture devices (i.e., blunt tip needles or non-needle
devices) [2].
Various non-penetrating placebo acupuncture de-
vices such as Streitberger’s needle, the Park sham
device (PSD), and the Takakura needle have been
developed. The first device, Streitberger’s needle, was
developed in 1998 and used a plastic ring covered with
a plastic sheet to place the needle [3]. When the prac-
titioner taps the needle, it moves inside the handle
and appears as if the acupuncture needle punctures
the skin. However, it does not puncture the skin, but
only a pricking sensation is felt by the patient because
the tip is blunt.
In 1999, Park et al. developed the PSD which was
similar to Streitberger’s needle [4]. The PSD included a
flange with adhesive tape and a guide tube to place the
placebo needle on the acupuncture point, while Streit-
berger’s needle used a plastic ring and sheet. Although
these two placebo acupuncture devices were successfully
applied to blinded participants and their use validated,
there still remains the limitation that they induce
physiological activity by touching the skin.
In 2014, Lee et al. developed a novel form of placebo
acupuncture, phantom acupuncture, which induces
participant expectation without any tactile stimulation
such as palpation, needle insertion, or manipulation
and which was also validated using blinded partici-
pants [5]. However, complex equipment is needed to
perform phantom acupuncture. Therefore, it may be
difficult to apply phantom acupuncture in clinical
acupuncture trials.
Although various placebo acupuncture devices have
been developed and used in acupuncture research,
there is controversy concerning whether these devices
are really appropriate for placebo control groups.
This trial will evaluate various placebo acupuncture
devices that have been used in acupuncture clinical trials
using a validation test to determine if they are suitable
to be used in control groups.
Methods/Design
Objectives
The objectives of this trial are to evaluate the validity
of different types of placebo acupuncture devices and
determine their suitability for use as placebos in clinical
trials.
Trial design and study setting
This study will be a single center, prospective, randomized,
random sequence, participant and assessor blinded trial
with two parallel arms.
We will conduct the study in the Kyung Hee University
Medical Center.
There are arm1 (Group1) and arm2 (Group2) in our
trial that is separated. Each group has three different
intervention sessions in random sequence. The order of
intervention will be randomized.
Inclusion and exclusion criteria
Participants who meet the following criteria will be
included irrespective of previous acupuncture experi-
ence: (1) healthy participants 20–50 years old, and (2)
participants who can communicate and complete the
questionnaire.
Participants will be excluded if they meet any of the
following criteria: (1) individuals who have taken medi-
cations during the prior month that could influence trial
results (e.g. medications for epilepsy, depression, panic
disorders, schizophrenia, etc.), (2) pregnant or breast-
feeding women, (3) Korean Medicine Doctors (KMD) or
Korean Medicine University students (because we think
that they can distinguish between placebo and real
acupuncture better than the general population), (4)
individuals who drank alcohol or coffee, or overworked
the day before or the day of the experiment, and (5)
individuals who are determined to be unsuitable for
following the study protocol by the researcher.
Recruitment
We will upload an advertisement to the hospital and
university homepages, and place a poster advertisement
on the bulletin boards of the hospital and university.
Potential participants will call the clinical research
coordinator (CRC) and will be pre-screened for eligibil-
ity. Eligible participants will make an appointment.
When potential participants visit the hospital, the inves-
tigator will provide information about volunteering and
explain the risks and benefits of the research. When the
individuals agree to enroll in the research, they will sign
an informed consent form.
Randomization and allocation concealment
After signing the informed consent form, the participants
will be randomized to Group 1 or Group 2. Group 1 will
receive the Real Streitberger’s needle (Real ST), Sham
Streitberger’s needle (Sham ST), and Phantom acupunc-
ture (PHNT); Group 2 will receive the PSD with a real
needle (Real Park), the PSD with a sham needle (Sham
Park), and no treatment (No treat). The treatment orders
in both groups will be randomized. A computerized bal-
anced block randomization will be performed by an in-
dependent clinical research coordinator (CRC) using R
version 3.1.2 with ‘block random’ function. The CRC will
send an e-mail regarding the name, random number, and
treatment order of enrolled participants to the practi-
tioners and operators. This e-mail will be documented in
the trial master file (TMF).
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Blinding
Participants will be blinded in this trial. However, it is
almost impossible to blind practitioners and operators
because they need to know which acupuncture devices
to use. They will not be allowed to communicate with
the participants concerning the type of acupuncture devices
and the purpose of the study. Outcome assessors and statis-
ticians will also be blinded to treatment allocation.
Intervention
Study flow
The study flow will be as follows. Group 1 will consist of
Sham ST, Real ST, and PHNT. Group 2 will consist of
Real Park, Sham Park, and No treatment. Groups 1 and 2
are separate groups; participants allocated to Group 1 will
not receive Real Park, Sham Park, and No treatment and
vice versa. Participants will have a total of three sessions
(acupuncture or no treatment) in a day (Fig. 1). Before
acupuncture treatment, the investigator will explain to
participants that they will receive three different types of
acupuncture except for the no treatment session. Partici-
pants will not know that placebo acupuncture occurred
until all sessions are completed. To avoid order effect, the
order of the three treatment sessions in each group will be
randomly assigned by the CRC. Before the first session,
the CRC will collect demographic information (e.g., age,
sex) and baseline data (e.g., vital signs, acupuncture
expectation questionnaire (AEQ) [6], and bodily sensation
questionnaire (BSQ)). After each treatment session, partic-
ipants will complete the blinding test questionnaire 1
(BTQ 1) and acupuncture sensation questionnaire (ASQ)
and will be asked about adverse events (AEs). After
completion of the third BTQ 1 and ASQ, an independent
assessor will inform the participants of the use of placebo
acupuncture and instruct them to complete the blinding
test questionnaire 2 (BTQ 2).
Procedures of each session
Physiological data including heart rate (HR) and skin
conductance response (SCR) will be measured by an
operator during each session to quantify the auto-
nomic nervous system (ANS) response (Fig. 2). We
will record three tonic responses (before, during, and
after acupuncture treatment) and one phasic response
(during stimulation).
1. Stabilization: After all preparations (e.g., attaching
electrodes, checking the ECG and SCR wave
patterns) are complete, participants will lie on the
bed for 5 to10 min to stabilize.
2. Tonic response before acupuncture: We will
measure the tonic ANS response before acupuncture
treatment during 5 min of resting.
3. Needle insertion and rest: We will insert the
acupuncture needle and induce the de-qi sensation for
1 min and explain to participants that the response
induced by needle insertion will be measured. To
minimize the influence of the acupuncture insertion,
participants will be rested for 1 min.
4. Phasic response during stimulation: The practitioner
will approach her hand to the left ST 36
acupuncture point and rotate the needle eight times
within 3 min according to an audio signal relayed
via a headphone. The stimulation timing will be
pseudo-randomly set by computer (Psychtoolbox
and Matlab, The MathWorks Inc., MA, USA).
5. Rest: To minimize the influence of the acupuncture
stimulation, participants will be rested for 1 min.
6. Tonic response during acupuncture: We will
measure the tonic ANS response for 5 min during
acupuncture treatment.
7. Needle removal and rest: We will remove the
acupuncture needle for 1 min. To minimize the
Fig. 1 Study flow. AEQ indicates acupuncture expectation questionnaire, BSQ bodily sensation questionnaire, BTQ2 blinding test questionnaire 2,
R randomization
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influence of the acupuncture needle removal,
participants will be rested for 1 min.
8. Tonic response after acupuncture: We will measure
the tonic ANS response for 5 min after the
acupuncture needle is removed.
Acupuncture treatment setting and equipment
The acupuncture treatment room setting will be modified
from a previous study by Lee et al. [5] and is shown in Fig. 3.
Participants will lie on the bed in a supine position. A visual
barrier will prevent participants from viewing their leg and
the acupuncture treatment procedure directly.
Acupuncture stimulation will be recorded simultan-
eously and will be shown to the participants through a
ceiling monitor in real time for 3 min. Before the
stabilization phase, the operator will show the acupunc-
ture point and movement of their legs through the ceiling
monitor so that participants will have body ownership via
the image.
Details of the acupuncture treatment plans are shown
in Table 1.
Phantom acupuncture and no treatment session
In PHNT, practitioners will not provide any tactile
stimulation and will only approach their hand to the left
ST 36 acupuncture point without touching. A recorded
video clip of the participant’s Real ST session will be
played during the PHNT session. If the PHNT session is
scheduled as the first session, we will play a video from
another participant with similar skin color and leg hair.
In the No treatment session, practitioners will inform
participants that they will not receive any treatment. A
blinding questionnaire will not be completed; recorded
physiological data will be used as a baseline. In order to
ensure comparability, participants will undergo the same
procedure except they will be shown a 3 min video clip
that is not related to acupuncture but has a similar back-
ground color and shows some type of artificial movement
Fig. 2 Acupuncture treatment schedule and ANS measurement. ASQ indicates acupuncture sensation questionnaire, BTQ1 blinding
test questionnaire1
Fig. 3 Acupuncture treatment setting
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Table 1 Details of acupuncture treatments (STRICTA 2010 checklist)
Item Detail
1. Acupuncture rationale 1a) Style of acupuncture Manual acupuncture based on traditional Korean
medicine theory
1b)Reasoning for treatment provided, based on
historical context, literature sources, and/or
consensus methods, with references
where appropriate
Consensus of the KMD
1c)Extent to which treatment was varied All participants will receive standardized treatment
2. Details of needling 2a) Number of needle insertions per subject
per session
1
2b) Names of points used Left ST36
2c) Depth of insertion, based on a specified
unit of measurement
15 mm
2d) Response sought De-qi
2e) Needle stimulation : During 3 min of phasic session, manual stimulation
will be conducted eight times based on an audio
signal received via a headphone. Interval between
each manual stimulation is from 10 to 14 s. For
each manual stimulation, the acupuncture needle
will be rotated five times during 3 s.
2f) Needle retention time 11 min
2g) Needle type [Group 1] Real Streitberger’s needle; 0.25 × 40 mm
sterilized stainless steel needle (Asia-med GmbH
& Co. KG, Kirchplatz 1, Germany).
[Group 2] PSD; 0.25 × 40 mm sterilized stainless
steel needle (Park sham Device, Acuprime, Exter, UK).
3. Treatment regimen 3a) Number of treatment sessions 3 sessions
3b) Frequency and duration of treatment sessions 3 sessions for 1 day
(30 min washout period between each session)
4. Other components of treatment 4a) Details of other interventions administered
to the acupuncture group
None
4b) Setting and context of treatment, including
instructions to practitioners, and information
and explanations to patients
The study will be conducted in the Kyung Hee
University Medical Center. All information except
the objective of trial and acupuncture types will
be provided to the participants.
5. Practitioner background 5) Description of participating acupuncturists Licensed KMD with at least 5 years of clinical
practice experience
6. Control interventions 6a) Rationale for the control or comparator in
the context of the research question, with
sources that justify this choice
Validated placebo acupuncture devices will be
used in control sessions.
6b) Precise description of the control or comparator.
If sham acupuncture or any other type of
acupuncture-like control is used, provide details as
for Items 1 to 3 above.
The order of three treatments in each group will
be randomized.
[GROUP 1]1) Sham Streitberger’ needle: 0.25 × 40
mm sterilized stainless steel needle (Special No. 16
of Asia-med GmbH & Co. KG, Kirchplatz 1,Germany)
will be used.The appearance, acupuncture point,
stimulation method, and duration will be the same
with the real Streitberger’s needle.
2) Phantom acupuncture: There is no tactile
stimulation to ST 36. To induce credibility that
participants are treated with acupuncture, the
video clip of the previously recorded Streitberger’s
needle session will be shown.
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BTQ 1 : After each acupuncture session, participants
will complete the BTQ 1. BTQ1 consists of five ques-
tions. If a participant completes all five questions with-
out any doubt or asking, we will conclude blinding is
succeeded. If participants mention strange aspect of the
questionnaire or reply they did not receive acupuncture
treatment, conclude that blinding is failed. Otherwise,
we will conclude that blinding is succeeded.
Secondary endpoints
Bang’s blinding index (BI) After all the sessions are
finished, participants will complete the BTQ 2. At this
time, participants will be told that a placebo acupunc-
ture session occurred. We will calculate the BI from the
BTQ 2 [7]. The range of BI is −100 to 100 %; 0 % means
random guessing (e.g., 50 % correct and 50 % incorrect)
and 100 % means complete unblinding (i.e., all responses
are correct), −100 % means opposite of guessing (e.g., all
responses are incorrect) [8]. Thus, the BI is the propor-
tion of participants who guessed their treatment arm
correctly beyond chance [9, 10].
Massachusetts General Hospital (MGH) Acupuncture
Sensation Scale (MASS) Index by de-qi sensation
questionnaire (DSQ) The MASS measures the sensa-
tion caused by acupuncture stimulation. It consists of 12
descriptions: soreness, aching, deep pressure, heaviness,
fullness/distention, tingling, numbness, sharp pain, dull
pain, warmth, cold, and throbbing. The MASS index is a
weighted average based on a formula [11]. We will
determine the MASS using the DSQ.
Heart rate, heart rate variability, and skin conduct-
ance response Participants will rest for 5 to10 min
before we measure their tonic response to stabilize the
electrocardiogram and SCR wave pattern. We will record
the HR and SCR throughout the study using a PowerLab
Data acquisition system/800, Bio amplifier/ML132, GSR
Amplifier/ML116 (AD instruments, Australia) with a
400 Hz sampling rate. To measure HR, participants will
be placed on the bed and three electrodes (3M dispos-
able PAD 2223) will be attached beneath the clavicles
and the left rib. Then, we will remove power noise
frequency at 60 Hz and detect the R peak to measure
the HR. To measure the SCR, we will apply a gel to the
index and third fingers and attach electrodes [5, 12].
The HR and SCR will be measured during the tonic
and phasic responses. For the tonic responses, the mean
HR and SCR will be measured before, during, and after
the acupuncture treatment session for 5 min.
The HRV will be calculated by evaluating the R peak.
In the time domain analysis, we will calculate the stand-
ard deviation of all R-R intervals (SDNN) and the root-
mean-square of the successive difference (RMS-SD). For
the frequency domain analysis, we will calculate the high
frequency value (HF), low frequency value (LF), total
power, and the LF/HF ratio [13, 14].
In the phasic event related SCR responses, the average
of the maximum score change and the area under the
curve (AUC) will be estimated. We will also calculate
the stimulation/baseline SCR ratio of the score change
and the AUC.
Sample size calculation
This will be a kind of mechanism study, so we did not
follow the general method to calculate sample size. It is
known that a sample size of 12 or more is adequate for
a pilot study [15, 16]. We concluded that we will have
sufficient analytical power if our sample size is greater
than 12. We decided that we need to enroll at least 30
participants in our pilot study for each session assuming
a drop-out rate of approximately 20 %. We calculated a
sample size of 37.5 and rounded to this to 38 resulting
in a total sample size of 76 participants.
Statistical analysis
As our design has two independent groups that acquire
comparability by randomization, we can compare
variables not only within each group, but also between
groups.
The primary outcome of our research will be to com-
pare the blinding rates of the placebo acupuncture devices
Table 1 Details of acupuncture treatments (STRICTA 2010 checklist) (Continued)
[GROUP 2]1) PSD with sham needle: 0.25 × 40 mm
sterilized stainless steel needle (Park sham Device,
Acuprime, Exter, UK) will be used. The appearance,
acupuncture point, stimulation method, and depth
will be the same with the PSD as with the real
needle. 2) No treatment: There is no acupuncture
treatment. To induce the attention effect as in the
other sessions, a neutral image will be provided
instead of an acupuncture treatment image.
KMD Korean Medicine Doctor; PSD park sham device
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studied within and between groups. We will also con-
duct several exploratory secondary outcome analyses.
Expectation for acupuncture (measured by AEQ) [6],
previous acupuncture experiences, and age will be
considered as covariates. We will analyze physiological
data in three tonic responses (before, during, and after
acupuncture) and during phasic responses. We will not
statistically compare the Bang’s BI [9]. Instead, we will
calculate the point estimate and 95 % confidence interval
of Bang’s BI.
For dichotomous variables (i.e., blinding rate), within
group comparison will be performed using Cochran’s Q
test for Group 1 (Sham ST, Real ST, and PHNT) and
McNemar’s test for Group 2 (Sham, Real Park). We will
not check the blinding of the No treatment session.
Comparisons of blinding rates between group devices
(Sham ST vs Sham Park or PHNT vs Sham Park) will be
performed using the chi-square test, and comparisons
within group devices (PHNT vs Sham ST) will be
performed using McNemar’s test. For continuous vari-
ables (i.e., the MASS index, De-qi sensation, physio-
logical data such as HR, HRV, and SCR), within
group comparisons will be performed using repeated
measured ANOVA for Group 1 and paired t-test for
Group 2. We will use the independent t test for com-
parisons between group.
When we analyze physiological data, we will use the
both change ratio contrast to baseline and absolute
value. Change ratio and absolute value of HR and
SCR will be compared for three separate windows
during the tonic responses (before vs during vs after
acupuncture session). As absolute change value is
very dependent on baseline value, it will be used as
covariates.
Quality control
Before the study begins, we will conduct several simula-
tions using our colleagues and volunteers to identify any
problems with our study protocol. Practitioners will
conduct acupuncture sessions according to the standard
operating procedure (SOP) of our study. We will have
researcher meetings regularly to discuss issues that may
be raised by investigators and participants such as
protocol revisions, serious adverse events, and partici-
pant recruitment.
Safety and adverse event outcomes
When each session is completed, the assessor will ask if
any AE occurred and it will be documented in the CRF.
If any AEs occur, the type of AE, start/end date, severity,
manner of report, course, outcome, causality with acu-
puncture treatment, and actions taken will be docu-
mented and appropriate treatment will be provided to
the participants.
Ethics approval and registration
This study has been approved by the Institutional Review
Board of Kyung Hee University Korean Medicine Hospital
(KOMCIRB-140923-HR-008). Written informed consent
will be obtained from all participants. This study has
been registered with the Clinical Research Informa-
tion Service (CRIS), Republic of Korea, KCT0001347
(registered: January 15th, 2015).
Discussion
This trial was designed to investigate if various pla-
cebo acupuncture devices are appropriate for control
groups in acupuncture research. We will evaluate the
blinding of participants and also measure physiological
parameters such as HR, HRV, and SCR. In addition,
we will investigate the effects of various factors on
blinding and physiological parameters. We will exam-
ine the effects of the bodily sensation, de-qi sensation
(i.e., acupuncture-evoked sensations including nu-
mbness, heaviness, soreness, or distention), or patient
expectation for acupuncture on blinding and physio-
logical parameters.
Acupuncture treatment is composed of a variety of
components such as acupuncture point selection, skin
penetration, stimulation dose (diameter, length, and
number of needles, needling depth, and stimulation
method), patient expectation, and practitioner-patient
relationship [2]. However, studies on how each factor
affects the total therapeutic effect are lacking. In this
study, we are going to dis-associate a range of acupu-
ncture treatment factors using a validation test of three
types of placebo acupuncture techniques that have
different components.
Other researchers have developed placebo acupuncture
devices and evaluated their relevance using validation
tests.
Streitberger et al. performed a validation study that
investigated if acupuncture- naïve healthy participants
(n = 60) could feel the difference between a real acupunc-
ture needle and a placebo acupuncture device [3]. They
showed that the participants could not distinguish between
the two needles and suggested Streitberger’s needle as a
credible placebo treatment. Also White et al. conducted a
validation test of Streitberger’s needle in participants wait-
ing for orthopedic hip and knee joint replacement [17].
Most participants could not distinguish penetration
with a real acupuncture needle from that with a pla-
cebo needle. However, in two similar treatments, al-
most 40 % were able to discern a difference between
real and placebo acupuncture treatment administered
by the male practitioner only. This shows that it is
important how two interventions are delivered and
that standardization of treatment technique is strictly
required.
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The PSD developed by Park et al. was validated in two
randomized controlled trials (RCTs) in acute stroke
patients and acupuncture-naïve, healthy volunteers [18].
The study was designed to evaluate if PSD was indistin-
guishable from a real acupuncture needle and if PSD
induced de-qi. They found that PSD was indistinguishable
and inactive (in terms of de-qi), thus it is a valid placebo
control for acupuncture research.
However, these previous two devices touch the skin and
thus induce a physiological effect. To overcome this limi-
tation, Lee et al. developed a phantom acupuncture tech-
nique that imitates the acupuncture treatment ritual
without any tactile stimulation [5]. They showed the cred-
ibility of phantom acupuncture without somatosensory
components of real acupuncture in healthy participants.
In summary, three types of placebo acupunctures were
all evaluated to blinded participants using validation
tests. In this study, by measuring blinding, de-qi sensa-
tion, and various physiological parameters such as HR,
HRV, and SCR, we will investigate if placebo acupunc-
ture techniques are indistinguishable from real acupunc-
ture and physiologically inert.
This trial will evaluate the relevance of using placebo
acupuncture devices in control groups using a validation
test of various placebo acupuncture devices that have
been used in acupuncture research.
Trial status
This trial is currently recruiting participants.
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